Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Dose Reduction in Overtreated Psoriasis
NCT05683054Phase 4Completed
- Sponsor
- Ghent University Hospital
- Start
- Aug 2020
- Primary completion
- Mar 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of adalimumab in plaque psoriasis, sponsored by Ghent University Hospital. Started Aug 2020; status: completed.
02
Drugs
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT05683054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05683054.